A Termine

Galectin-3 is a presurgical marker of human thyroid carcinoma.

Fabio Orlandi, Enrico Saggiorato, Giovanni Pivano et al. · PubMed · 1998 · 218 citations

Medicine, Oncology, Pathology +17

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Fulvia Daffara, Silvia De Francia, Giuseppe Reimondo et al. · Endocrine Related Cancer · 2008 · 165 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Immediate Fall of Bone Formation and Transient Increase of Bone Resorption in the Course of High-Dose, Short-Term Glucocorticoid Therapy in Young Patients with Multiple Sclerosis

Andrea Dovio, Laura Perazzolo, G. Osella et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 161 citations

Medicine, Endocrinology, Bone Metabolism +16

The corticotrophin‐releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome

Giuseppe Reimondo, P. Paccotti, Marco Alessandro Minetto et al. · Clinical Endocrinology · 2003 · 126 citations

Medicine, Endocrinology, Internal Medicine +16

AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers

W. Debernardi‐Venon, Silvia Martini, Fiorella Biasi et al. · Journal of Hepatology · 2007 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +17